Seeking Alpha

KERX
  Keryx Biopharmaceuticals, Inc. - NASDAQ

8/21/2014, 4:14 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
KERX vs. ETF Alternatives
Company Description
Keryx Biopharmaceuticals, Inc., is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease. It is developing ZerenexTM an oral, ferric iron-based compound.